Commonwealth Equity Services’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$652K Buy
214,574
+54,200
+34% +$162K ﹤0.01% 3099
2026
Q1
$494K Sell
160,374
-21,109
-12% -$89.6K ﹤0.01% 3220
2025
Q4
$655K Buy
181,483
+7,386
+4% +$32.2K ﹤0.01% 2941
2025
Q3
$656K Buy
174,097
+75,176
+76% +$290K ﹤0.01% 2963
2025
Q2
$383K Buy
98,921
+9,245
+10% +$50K ﹤0.01% 3378
2025
Q1
$448K Buy
89,676
+3,582
+4% +$22.7K ﹤0.01% 3113
2024
Q4
$621K Sell
86,094
-3,026
-3% -$23.1K ﹤0.01% 2785
2024
Q3
$547K Buy
89,120
+2,010
+2% +$13.6K ﹤0.01% 2827
2024
Q2
$579K Buy
87,110
+7,165
+9% +$52.9K ﹤0.01% 2710
2024
Q1
$814K Buy
79,945
+19,172
+32% +$195K ﹤0.01% 2401
2023
Q4
$684K Buy
60,773
+19,763
+48% +$82.5K ﹤0.01% 2449
2023
Q3
$107K Buy
41,010
+3,945
+11% +$11.3K ﹤0.01% 3556
2023
Q2
$131K Buy
37,065
+6,696
+22% +$30.1K ﹤0.01% 3523
2023
Q1
$128 Buy
30,369
+13,820
+84% +$164K ﹤0.01% 3441
2022
Q4
$272K Hold
16,549
﹤0.01% 2948
2022
Q3
$211K Buy
+16,549
New +$244K ﹤0.01% 3117
2021
Q4
Sell
-19,255
Closed -$217K 3646
2021
Q3
$217K Sell
19,255
-482
-2% -$5.86K ﹤0.01% 3205
2021
Q2
$194K Buy
19,737
+7,802
+65% +$107K ﹤0.01% 3275
2021
Q1
$168K Buy
+11,935
New +$193K ﹤0.01% 3177
2018
Q3
Sell
-333
Closed -$4K 2788
2018
Q2
$4K Hold
333
﹤0.01% 2761
2018
Q1
$11K Buy
+333
New +$16.7K ﹤0.01% 2691

Other funds holding ALT

Commonwealth Equity Services's ALT Position: Q2 2026 in Review

Commonwealth Equity Services increased its Altimmune (ALT) stake by 34% in Q2 2026, buying an estimated $162K and bringing the position to 214,574 shares worth $652K. The position accounts for ﹤0.01% of the portfolio, ranked #3099.

Commonwealth Equity Services first reported a position in ALT in Q1 2018 and has held it in 21 quarters since. The position peaked at $814K in Q1 2024. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Commonwealth Equity Services held 214,574 shares of Altimmune worth $652K as of Q2 2026.
  • Commonwealth Equity Services bought 54,200 Altimmune shares in Q2 2026, an estimated $162K.
  • Altimmune made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3099 holding.
  • Commonwealth Equity Services first reported a position in Altimmune in Q1 2018 and has held it in 21 quarters since.
  • Commonwealth Equity Services's Altimmune position peaked at $814K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.